SG46649A1 - Compositions - Google Patents
CompositionsInfo
- Publication number
- SG46649A1 SG46649A1 SG1996007136A SG1996007136A SG46649A1 SG 46649 A1 SG46649 A1 SG 46649A1 SG 1996007136 A SG1996007136 A SG 1996007136A SG 1996007136 A SG1996007136 A SG 1996007136A SG 46649 A1 SG46649 A1 SG 46649A1
- Authority
- SG
- Singapore
- Prior art keywords
- pct
- sec
- date
- date dec
- pub
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000002585 base Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 229940116364 hard fat Drugs 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929209882A GB9209882D0 (en) | 1992-05-07 | 1992-05-07 | Compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG46649A1 true SG46649A1 (en) | 1998-02-20 |
Family
ID=10715158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996007136A SG46649A1 (en) | 1992-05-07 | 1993-05-05 | Compositions |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US5705506A (cs) |
| EP (1) | EP0639072B1 (cs) |
| JP (1) | JPH07506570A (cs) |
| KR (1) | KR100253111B1 (cs) |
| AT (1) | ATE163850T1 (cs) |
| AU (1) | AU670083B2 (cs) |
| BE (1) | BE1007024A5 (cs) |
| BG (1) | BG62120B1 (cs) |
| BR (1) | BR1100108A (cs) |
| CA (1) | CA2135179C (cs) |
| CH (1) | CH685920A5 (cs) |
| CY (1) | CY2039B1 (cs) |
| CZ (1) | CZ283512B6 (cs) |
| DE (1) | DE69317418T2 (cs) |
| ES (1) | ES2113533T3 (cs) |
| FR (1) | FR2690847B1 (cs) |
| GB (2) | GB9209882D0 (cs) |
| GR (1) | GR3026584T3 (cs) |
| HK (1) | HK95697A (cs) |
| HU (2) | HU227338B1 (cs) |
| IE (1) | IE75203B1 (cs) |
| IL (1) | IL105468A (cs) |
| IT (1) | IT1261471B (cs) |
| NO (1) | NO306700B1 (cs) |
| NZ (1) | NZ252132A (cs) |
| OA (1) | OA10109A (cs) |
| RO (1) | RO112993B1 (cs) |
| RU (1) | RU2118527C1 (cs) |
| SG (1) | SG46649A1 (cs) |
| TW (1) | TW231970B (cs) |
| UA (1) | UA37206C2 (cs) |
| WO (1) | WO1993021916A1 (cs) |
| ZA (1) | ZA933178B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2434297A (en) * | 1996-05-23 | 1997-12-09 | Alcon Laboratories, Inc. | The use of 5-ht1b/1d agonists to treat ocular pain |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| US6440458B1 (en) * | 1998-03-26 | 2002-08-27 | Fujisawa Pharmaceutical Co., Ltd. | Sustained release preparations |
| US7704958B1 (en) * | 1999-03-05 | 2010-04-27 | Bio Holding, Inc. | Methods and compositions for inhibiting apoptosis using serine protease inhibitors |
| AR056690A1 (es) * | 2005-10-14 | 2007-10-17 | Athersys Inc | Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc |
| EP2124556B1 (en) | 2006-10-09 | 2014-09-03 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
| EP2240022B1 (en) | 2008-01-09 | 2016-12-28 | Charleston Laboratories, Inc. | Bilayered tablets comprising oxycodone and promethazine |
| WO2011006012A1 (en) | 2009-07-08 | 2011-01-13 | Charleston Laboratories Inc. | Pharmaceutical compositions |
| EP2627328B1 (en) | 2010-10-15 | 2016-09-14 | Contera Pharma APS | Combinations of serotonin receptor agonists for treatment of movement disorders |
| KR102104635B1 (ko) | 2012-04-18 | 2020-04-27 | 콘테라 파르마 에이피에스 | 운동 장애의 개선된 관리에 적합한 경구로 이용 가능한 약학적 제형 |
| US10179109B2 (en) | 2016-03-04 | 2019-01-15 | Charleston Laboratories, Inc. | Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates |
| AU2017297718B2 (en) | 2016-07-11 | 2023-06-08 | Contera Pharma A/S | Pulsatile drug delivery system for treating morning akinesia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ197998A (en) * | 1980-08-12 | 1985-08-16 | Glaxo Group Ltd | 5-amino(methyl)-1h-indol-3-ylalkaneamines |
| ZW19381A1 (en) * | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
| GB2082175B (en) * | 1980-08-12 | 1984-05-02 | Glaxo Group Ltd | Heterocyclic compounds |
| IT1170387B (it) * | 1982-06-07 | 1987-06-03 | Glaxo Group Ltd | Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono |
| GB8332435D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
| GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
| GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
| DE3542698A1 (de) * | 1984-12-04 | 1986-06-05 | Glaxo Group Ltd., London | Indolderivate, verfahren zu ihrer herstellung und sie enthaltende, pharmazeutische zubereitungen |
| GB8431426D0 (en) * | 1984-12-13 | 1985-01-23 | Glaxo Group Ltd | Chemical compounds |
| DE3678805D1 (de) * | 1985-11-08 | 1991-05-23 | Glaxo Group Ltd | Indolderivate. |
| PH24976A (en) * | 1987-08-13 | 1990-12-26 | Glaxo Group Ltd | Indole derivatives |
| CA2282890C (en) * | 1990-06-07 | 2001-07-31 | The Wellcome Foundation Limited | Therapeutic heterocyclic compounds |
-
1992
- 1992-05-07 GB GB929209882A patent/GB9209882D0/en active Pending
-
1993
- 1993-04-20 IL IL10546893A patent/IL105468A/en not_active IP Right Cessation
- 1993-05-03 US US08/331,485 patent/US5705506A/en not_active Expired - Fee Related
- 1993-05-03 NZ NZ252132A patent/NZ252132A/en not_active IP Right Cessation
- 1993-05-03 CZ CZ942723A patent/CZ283512B6/cs not_active IP Right Cessation
- 1993-05-03 HU HU9403188A patent/HU227338B1/hu unknown
- 1993-05-03 DE DE69317418T patent/DE69317418T2/de not_active Expired - Lifetime
- 1993-05-03 RO RO94-01790A patent/RO112993B1/ro unknown
- 1993-05-03 ES ES93909884T patent/ES2113533T3/es not_active Expired - Lifetime
- 1993-05-03 AU AU40640/93A patent/AU670083B2/en not_active Ceased
- 1993-05-03 RU RU94046069/14A patent/RU2118527C1/ru not_active IP Right Cessation
- 1993-05-03 EP EP93909884A patent/EP0639072B1/en not_active Expired - Lifetime
- 1993-05-03 CA CA002135179A patent/CA2135179C/en not_active Expired - Fee Related
- 1993-05-03 JP JP5518928A patent/JPH07506570A/ja active Pending
- 1993-05-03 WO PCT/EP1993/001077 patent/WO1993021916A1/en active IP Right Grant
- 1993-05-03 UA UA94115989A patent/UA37206C2/uk unknown
- 1993-05-03 AT AT93909884T patent/ATE163850T1/de active
- 1993-05-05 SG SG1996007136A patent/SG46649A1/en unknown
- 1993-05-05 GB GB9309209A patent/GB2266665B/en not_active Expired - Lifetime
- 1993-05-06 FR FR9305432A patent/FR2690847B1/fr not_active Expired - Lifetime
- 1993-05-06 ZA ZA933178A patent/ZA933178B/xx unknown
- 1993-05-06 IE IE930339A patent/IE75203B1/en not_active IP Right Cessation
- 1993-05-06 BE BE9300467A patent/BE1007024A5/fr not_active IP Right Cessation
- 1993-05-06 IT ITRM930286A patent/IT1261471B/it active IP Right Grant
- 1993-05-06 CH CH139793A patent/CH685920A5/fr not_active IP Right Cessation
- 1993-05-12 TW TW082103742A patent/TW231970B/zh active
-
1994
- 1994-11-04 NO NO944214A patent/NO306700B1/no not_active IP Right Cessation
- 1994-11-04 OA OA60578A patent/OA10109A/en unknown
- 1994-11-05 KR KR1019940703950A patent/KR100253111B1/ko not_active Expired - Fee Related
- 1994-11-07 BG BG99167A patent/BG62120B1/bg unknown
-
1995
- 1995-06-29 HU HU95P/P00531P patent/HU211638A9/hu unknown
-
1996
- 1996-12-24 BR BR1100108-9A patent/BR1100108A/pt active IP Right Grant
-
1997
- 1997-06-26 HK HK95697A patent/HK95697A/xx not_active IP Right Cessation
-
1998
- 1998-04-10 GR GR980400773T patent/GR3026584T3/el unknown
- 1998-04-30 CY CY9802039A patent/CY2039B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9702865A (es) | Agentes estrogenicos. | |
| BG105564A (en) | Galantamine-containing composition with controlled release | |
| MY117274A (en) | Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present. | |
| EP0903349A3 (en) | CCR-3 receptor antagonists | |
| ES2160949T3 (es) | Derivados de fenilen-sulfonamida sustituidos en meta. | |
| WO2003037271A3 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| IL127244A (en) | Substituted amines, methods of their preparation and pharmaceutical compositions containing them | |
| DK0641328T3 (da) | Broforbundne, azabicykliske derivater som substans P-antagonister | |
| MY141384A (en) | Prevention of loss and restoration of bone mass by certain prostaglandin agonists | |
| IL140930A0 (en) | Compounds and compositions for delivering active agents | |
| ZA971279B (en) | Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors | |
| BG105534A (en) | 5ht1 means and method for the treatment of migraine | |
| GB9309209D0 (en) | Compositions | |
| IL114598A0 (en) | Triazole compounds their preparation and pharmaceutical compositions containing them | |
| IL114600A (en) | Thiazole and thiadiazole compounds their preparation and pharmaceutical compositions containing them | |
| GR3022615T3 (en) | Pharmaceutical compositions based on ebastime or analogues thereof. | |
| EP0485431A4 (en) | Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents | |
| GR3036195T3 (en) | Novel compounds | |
| BG102229A (en) | Endothelium receptor antagonists | |
| FR2724933B1 (cs) | ||
| HU9500175D0 (en) | Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives | |
| TW371661B (en) | Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides | |
| GR3026346T3 (en) | Pharmaceutical compositions comprising contignasterol compounds. | |
| CA2270026A1 (en) | Substituted bicyclic derivatives for treating central nervous system disorders | |
| IL150082A (en) | Unsaturated 14,15 - cyclopropane |